Skip to main content

Barbara M. Wirostko, MD

Languages spoken: English

Clinical Locations

  • Barbara M. Wirostko, MD, FARVO, is Moran’s Resident Research Director and Adjunct Professor of Ophthalmology and Biomedical Engineering. She has specialized fellowship training in glaucoma, is a board-certified ophthalmologist, and a Fellow of The Association of Research in Vision and Ophthalmology (ARVO).

    She treats glaucoma and comprehensive ophthalmology patients, specializes in clinical research, and advises drug development for glaucoma pharmaceutical therapies. As a serial entrepreneur for biotech startups, she has received millions in grants as the principal investigator (PI) for funding from the Department of Defense and National Science Foundation.

    Her research interest is in novel glaucoma therapeutics, sustained delivery of therapeutics for ocular pathologies, and better understanding the genetics and associated systemic diseases of exfoliative syndrome, a common cause of open-angle glaucoma.

    Dr. Wirostko has scored in the top 10 percent nationwide for patient satisfaction. Her honors include Moran’s Clinical Faculty of the Year Award in 2015 and the Third Annual Distinguished Alumni Award from the Edward S. Harkness Eye Institute, Columbia University.

    Her professional and scientific experience includes serving as associate editor for Ophthalmology Glaucoma, Acta Ophthalmologica, and Journal of Glaucoma. She’s an active committee member for ARVO and a scientific advisor for the California Institute of Regenerative Medicine, The Glaucoma Foundation, and the Glaucoma Research Foundation.

    Dr. Wirostko’s numerous grants include a new two-year project funded by a BrightFocus Foundation National Glaucoma Research award of nearly $180,000. The research project, “Prognostic Factors and Predictive Markers of Progression to Exfoliation Glaucoma in Exfoliation Syndrome,” will include a multi-disciplinary team of experts. She will serve as co-PI with Karen Curtin, PhD, MStat, with the Utah Population Database.

    Board Certification and Academic Information

    Academic Departments - Adjunct

    Patient Rating

    4.9/5

    The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

    Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Learn more about our survey

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    November 05, 2022

    Dr. Wirostko is beyond excellent!

    October 30, 2022

    Dr Wirostko is an extraordinarily physician! She is informed on the latest research, an excellent listener, and very compassionate.

    October 29, 2022

    Kind and thoughtful and informative

  • Barbara M. Wirostko, MD, FARVO, is Moran’s Resident Research Director and Adjunct Professor of Ophthalmology and Biomedical Engineering. She has specialized fellowship training in glaucoma, is a board-certified ophthalmologist, and a Fellow of The Association of Research in Vision and Ophthalmology (ARVO).

    She treats glaucoma and comprehensive ophthalmology patients, specializes in clinical research, and advises drug development for glaucoma pharmaceutical therapies. As a serial entrepreneur for biotech startups, she has received millions in grants as the principal investigator (PI) for funding from the Department of Defense and National Science Foundation.

    Her research interest is in novel glaucoma therapeutics, sustained delivery of therapeutics for ocular pathologies, and better understanding the genetics and associated systemic diseases of exfoliative syndrome, a common cause of open-angle glaucoma.

    Dr. Wirostko has scored in the top 10 percent nationwide for patient satisfaction. Her honors include Moran’s Clinical Faculty of the Year Award in 2015 and the Third Annual Distinguished Alumni Award from the Edward S. Harkness Eye Institute, Columbia University.

    Her professional and scientific experience includes serving as associate editor for Ophthalmology Glaucoma, Acta Ophthalmologica, and Journal of Glaucoma. She’s an active committee member for ARVO and a scientific advisor for the California Institute of Regenerative Medicine, The Glaucoma Foundation, and the Glaucoma Research Foundation.

    Dr. Wirostko’s numerous grants include a new two-year project funded by a BrightFocus Foundation National Glaucoma Research award of nearly $180,000. The research project, “Prognostic Factors and Predictive Markers of Progression to Exfoliation Glaucoma in Exfoliation Syndrome,” will include a multi-disciplinary team of experts. She will serve as co-PI with Karen Curtin, PhD, MStat, with the Utah Population Database.

    Board Certification and Academic Information

    Academic Departments -Adjunct

    Education history

    Fellowship Glaucoma - The New York Hospital, Cornell Medical Center Fellow
    Ophthalmology - Columbia Presbyterian Medical Center, Edward S. Harkness Eye Institute Resident
    Internship Hackensack Medical Center Intern
    Medicine - Columbia University M.D.
    Undergraduate Microbiology - Cornell University B.A.